MARTIN RANDEL S 4
4 · LUMINEX CORP · Filed Dec 2, 2003
Insider Transaction Report
Form 4
LUMINEX CORPLMNX
MARFIN RANDEL S
VP, Luminex Bioscience Group
Transactions
- Sale
Common Stock
2003-12-01$10.16/sh−20,400$207,248→ 0 total - Exercise/Conversion
Common Stock
2003-12-01$3.92/sh+20,400$79,968→ 20,400 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2003-12-01−20,400→ 0 totalExercise: $3.92Exp: 2004-05-20→ Common Stock (20,400 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a pre-planned trading program.
- [F2]The option became exercisable in three equal annual installments on May 20, 2000, 2001 and 2002.